R&D Sponsored Webinar recap: The future of cell and gene therapy in rare d... For decades, treatment options for rare diseases have been limited, often focusing on symptom management rather than addressing the root cause of them
Sales & Marketing Executing established pharma brand strategy: Key considerati... As blockbuster drug patents edge closer to expiry, pharma companies must rethink how they invest in, support, and scale established brands
Sales & Marketing Partner Content The ESG in Life Sciences Summit is coming to the West Coast! The ESG in Life Sciences Summit West is coming to San Francisco! (July 8-10, 2025).
R&D Partner Content World’s Largest Biopharma Forum for all mRNA Stakeholders The mRNA field is on the cusp of revolutionary change, with cancer vaccines, in vivo cell engineering and gene editing technologies unleashing the next advancements of therapeutic candidat
Sales & Marketing Partner Content Pharma Equipment Auction: Surepharm Assets Sale Bid on used pharmaceutical production and packaging equipment. View auction April 22-24.
R&D Partner Content 4th Liquid Biopsy for Precision Oncology East Coast Better Identify Disease Risk, Detect Recurrence & Understand Treatment Responses with Ultra-Sensitive & Highly Accurate Liquid Biopsy Tests that Posit
News Beren's Niemann-Pick drug Lembaz cleared by FDA The FDA has approved Beren's Lembaz for Niemann-Pick disease type C, the first drug shown to extend survival in the ultra-rare inherited disorder.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.